| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/23/2002 | WO2002040475A1 Bombesin receptor antagonists |
| 05/23/2002 | WO2002040471A2 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 05/23/2002 | WO2002040470A1 Imidazole derivatives, process for their preparation and their use |
| 05/23/2002 | WO2002040469A1 Bombesin receptor antagonists |
| 05/23/2002 | WO2002040468A1 Compounds |
| 05/23/2002 | WO2002040462A2 Cysteine protease inhibitors |
| 05/23/2002 | WO2002040457A1 Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor |
| 05/23/2002 | WO2002040451A2 Lactam compound |
| 05/23/2002 | WO2002040450A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors |
| 05/23/2002 | WO2002040446A1 Glucagon antagonist/inverse agonist |
| 05/23/2002 | WO2002040445A1 Glucagon antagonists/inverse agonists |
| 05/23/2002 | WO2002040041A2 Orally ingestible preparation of mistletoe lectins and method |
| 05/23/2002 | WO2002040038A2 M. tuberculosis chaperonin 10 and uses thereof |
| 05/23/2002 | WO2002040037A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | WO2002040025A1 Anti-inflammatory agents |
| 05/23/2002 | WO2002040022A1 Treatment of sexual dysfunction using bombesin antagonist |
| 05/23/2002 | WO2002040019A1 Benzimidazole derivatives |
| 05/23/2002 | WO2002040016A2 Association of calpain inhibitors and reactive oxygen species trapping agents |
| 05/23/2002 | WO2002040015A1 Protein prenyl transferase inhibitors in the treatment of neuroinflammatory disease |
| 05/23/2002 | WO2002040014A1 Fat composition for oral or enteral administration and hexacosanoic acid depressant |
| 05/23/2002 | WO2002040013A1 Composition for stimulating the immune defence and iron metabolism, containing propionyl l-carnitine and lactoferrin |
| 05/23/2002 | WO2002040009A1 Gaba enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 05/23/2002 | WO2002040008A2 Treatment of sexual dysfunction with non peptide bombesin receptor antagonists |
| 05/23/2002 | WO2002040007A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 05/23/2002 | WO2002040005A2 Blockade of sodium channels by phenol derivatives |
| 05/23/2002 | WO2002040004A1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 05/23/2002 | WO2002039995A2 Combination therapy for estrogen-dependent disorders |
| 05/23/2002 | WO2002039990A2 Method for screening anti-proliferative compounds and inhibiting tumor growth |
| 05/23/2002 | WO2002039989A1 Novel use of combined 5-ht1a agonists and selective serotonin reuptake inhibitors |
| 05/23/2002 | WO2002039988A2 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists |
| 05/23/2002 | WO2002039976A1 Use of 2-oxothiazolidine 4-carboxylic acid derivatives as agents promoting skin peeling |
| 05/23/2002 | WO2002039948A2 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 05/23/2002 | WO2002039834A1 Nutritional composition for an immune condition |
| 05/23/2002 | WO2002014313A3 Novel beta-amyloid inhibitors, method for producing the same and the use thereof as medicaments |
| 05/23/2002 | WO2002003970A3 Matrix controlled transdermal system for stabile derivatives of ace inhibitors |
| 05/23/2002 | WO2001093846A3 Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of clycosaminoglycans |
| 05/23/2002 | WO2001088103A9 Compositions and methods for tissue dedifferentiation and regeneration |
| 05/23/2002 | WO2001087882A3 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
| 05/23/2002 | WO2001087346A3 Dendritic cells loaded with toxic substances |
| 05/23/2002 | WO2001087284A3 Aldosterone antagonist composition for release during aldosterone acrophase |
| 05/23/2002 | WO2001085116A3 Synergistic antiplaque/antigingivitis oral composition |
| 05/23/2002 | WO2001083513A3 Antisense modulation of inhibitor of dna binding-1 expression |
| 05/23/2002 | WO2001083449A3 Rigid pyrrolidone modulators of pkc |
| 05/23/2002 | WO2001081577A3 Dna encoding the prost 03 polypeptide |
| 05/23/2002 | WO2001081340A3 Heterocycles that are inhibitors of impdh enzyme |
| 05/23/2002 | WO2001081316A3 Substituted phenyl farnesyltransferase inhibitors |
| 05/23/2002 | WO2001080845A3 (2-aminoethyl) oxime derivatives for the treatment of depression |
| 05/23/2002 | WO2001079444A3 Albumin fusion proteins |
| 05/23/2002 | WO2001079180A3 5-substituted tetralones as inhibitors of ras farnesyl transferase |
| 05/23/2002 | WO2001079179A3 Dihydro-2h-naphthalene-1-one inhibitors of ras farnesyl transferase |
| 05/23/2002 | WO2001079164A3 N-substituted dithiocarbamates for the treatment of biological disorders |
| 05/23/2002 | WO2001078692A3 Membrane delivery system |
| 05/23/2002 | WO2001077687A3 Prion-binding peptidic ligands and methods of using same |
| 05/23/2002 | WO2001076637A3 Peptide conjugates for drug delivery |
| 05/23/2002 | WO2001074394A8 New combination of a betablocker and a cholesterol-lowering agent |
| 05/23/2002 | WO2001074348A8 Vasopeptidase inhibitors to treat isolated systolic hypertension |
| 05/23/2002 | WO2001074344A3 Small organic molecule regulators of cell proliferation |
| 05/23/2002 | WO2001072707A3 Carbamate caspase inhibitors and uses thereof |
| 05/23/2002 | WO2001072294A3 Method of treating hepatitis delta viral infection |
| 05/23/2002 | WO2001053506A3 Virus strains for the oncolytic treatment of cancer |
| 05/23/2002 | WO2001049304A3 Aqueous ionic solutions and their uses in particular in ophthalmology |
| 05/23/2002 | WO2001047946A9 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 05/23/2002 | WO2001044206A9 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 05/23/2002 | WO2001041760A9 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 05/23/2002 | WO2001035941A3 Novel composition based on a thiazolidinedione and metformin and use |
| 05/23/2002 | WO2000063204A3 Substituted azoles |
| 05/23/2002 | US20020062031 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof |
| 05/23/2002 | US20020061932 Pharmaceutical composition |
| 05/23/2002 | US20020061924 Antiischemic agents, improving deformability of erythrocyte membrane and peripheral circulation |
| 05/23/2002 | US20020061923 Diacid isoindoleine amide derivative |
| 05/23/2002 | US20020061920 Selected fused pyrrolocarbazoles |
| 05/23/2002 | US20020061916 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 05/23/2002 | US20020061911 Enantiomers of 6-amino EM-12 and method of use |
| 05/23/2002 | US20020061910 Optically pure reboxetine or its methanesulfonate salt inhibits reuptake of norepinephrine |
| 05/23/2002 | US20020061906 Aerosol compositions |
| 05/23/2002 | US20020061898 Inhibitors of nucleoside metabolism |
| 05/23/2002 | US20020061892 Antiviral azaindole derivatives |
| 05/23/2002 | US20020061887 For therapy and prophylaxis of cardiovascular diseases such as hypertension, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis |
| 05/23/2002 | US20020061886 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 05/23/2002 | US20020061881 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 05/23/2002 | US20020061878 Diazacycloalkanedione derivatives |
| 05/23/2002 | US20020061877 Substituted cyclic amine metalloprotease inhibitors |
| 05/23/2002 | US20020061874 Substituted lactam; gamma-secretase inhibitor; decreases production of beta-amyloid; treatment for Altzheimer's and Down's syndrome |
| 05/23/2002 | US20020061873 Having high bioavailability levels and reduced variability of bioavailability by use of dispersed, colloidal structures, colloids or analogous structures of the drug, a hydrophilic component, and a surfactant |
| 05/23/2002 | US20020061872 For oral administration or embedded or otherwise attached to medical devices for blood collection and/or treatment |
| 05/23/2002 | US20020061866 Pharmaceutical compositions comprising in combination a bisphosphonate and a matrix metalloproteinase inhibitor |
| 05/23/2002 | US20020061865 Bicyclic heterocycles that inhibit cyclin-dependent kinase or tyrosine kinase enzymes, or both, for treatment of proliferative disorders |
| 05/23/2002 | US20020061860 Antisense oligonucleotide inhibition of specific histone deacetylase isoforms |
| 05/23/2002 | US20020061853 Caspase inhibtors and uses thereof |
| 05/23/2002 | US20020061852 Methods of therapy with thrombin derived peptides |
| 05/23/2002 | US20020061848 An specific polypeptides comprising a Chlamydia antigen and the use of such polypeptides for the serodiagnosis and treatement of Chlamydia infection |
| 05/23/2002 | US20020061844 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt |
| 05/23/2002 | US20020061843 Use of mCRP for delivery of materials into cells |
| 05/23/2002 | US20020061840 Tripeptide compounds useful as selective inhibitors of aminopeptidase A and corresponding pharmaceutical compositions |
| 05/23/2002 | US20020061589 Method of immunotherapy; obtain electrodes, obtain waveform generator, generate electrically conductive pathways between electrodes and generator, incubate with transfer particles, transfer particles into cells with electrical pulse |
| 05/23/2002 | US20020061569 Nuclelotide sequences for use in the prevention of proliferation of microorganisms |
| 05/23/2002 | US20020061559 Preferential protein for use in the diagnosis and treatment of cancers; antitumor agents; anticarcinogeneic agents |
| 05/23/2002 | US20020061304 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 05/23/2002 | US20020061294 Mononuclear phagocytes in therapeutic drug delivery |
| 05/23/2002 | US20020061281 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |